Mechanistically, S-adenosylmethionine (SAM), the key methyl donor derived from methionine metabolism, promotes N6-methyladenosine (m6A) modification of PD-L1 mRNA, thereby increasing its translational efficiency and facilitating tumor immune evasion. Here, CD274 is linked to neoplasm.